

Instance: composition-en-bbb651a1913e568b3035dea752ef36ea
InstanceOf: CompositionUvEpi
Title: "Composition for ivabradine Package Leaflet"
Description:  "Composition for ivabradine Package Leaflet"
Usage: #inline

* identifier.system = ""

* identifier.value = "identifier"
* status = #final

* type = https://spor.ema.europa.eu/rmswi/#100000155538
* type.text = "Package Leaflet"

* subject = Reference(mock)
* date = "2022-02-16T13:28:17Z"

 

 // Reference to Organization: MAH
* author = Reference(mah-ema)


* title = "TEST PURPOSES ONLY - ivabradine"
* attester.mode = http://hl7.org/fhir/composition-attestation-mode#official
* attester.time =  "2022-02-16T13:28:17Z"
* language = #en
* category = epicategory-cs#R "Raw"


* section[+].
  * title = "B. Package Leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "B. Package Leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   


      
* section[=].section[+]
  * title = "Package leaflet: Information for the user"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "Package leaflet: Information for the user"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   



* section[=].section[+]
  * title = "What is in this leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "What is in this leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  What is in this leaflet  
1. What Ivabradine Accord is and what it is used for 
2. What you need to know before you take Ivabradine Accord 
3. How to take Ivabradine Accord 
4. Possible side effects 
5. How to store Ivabradine Accord 
6. Contents of the pack and other information 
         </div>"""   
          

* section[=].section[+]
  * title =  "1. What ivabradine is and what it is used for"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text =  "1. What ivabradine is and what it is used for"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Ivabradine Accord  is a heart medicine used to treat:</p>
<ul>
<li>Symptomatic stable angina pectoris (which causes chest pain) in adult patients whose heart rate 
is over or equal to 70 beats per minute. It is used in adult patients who do not tolerate or cannot 
take heart medicines called beta-blockers. It is also used in combination with beta-blockers in 
adult patients whose condition is not fully controlled with a beta-blocker. </li>
<li>Chronic heart failure in adult patients whose heart rate is over or equal to 75 beats per minute. 
It is used in combination with standard therapy, including beta-blocker therapy or when 
beta-blockers are contraindicated or not tolerated. </li>
</ul>
<p>About stable angina pectoris (usually referred to as  angina ): 
Stable angina is a heart disease which happens when the heart does not receive enough oxygenThe 
most common symptom of angina is chest pain or discomfort.<br />
About chronic heart failure: 
Chronic heart failure is a heart disease which happens when your heart cannot pump enough blood to 
the rest of your body. The most common symptoms of heart failure are breathlessness, fatigue, 
tiredness and ankle swelling. </p>
<p>How does Ivabradine Accord work? 
The specific heart rate lowering action of ivabradine helps :</p>
<ul>
<li>to control and reduce the number of angina attacks by lowering heart s need for oxygen, </li>
<li>to improve the heart functioning and vital prognosis in patients with chronic heart failure. </li>
</ul>         </div>"""   
          

             
* section[=].section[+]
  * title = "2. What you need to know before you take ivabradine"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "2. What you need to know before you take ivabradine"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Do not take Ivabradine Accord 
- if you are allergic to ivabradine or any of the other ingredients of this medicine (listed in 
section 6); 
- if your resting heart rate before treatment is too slow (below 70 beats per minute); 
- if you are suffering from cardiogenic shock (a heart condition treated in hospital); 
- if you suffer from a heart rhythm disorder (sick sinus syndrome, sino-atrial block, AV-block of 3rd 
degree); 
- if you are having a heart attack; 
- if you suffer from very low blood pressure; 
- if you suffer from unstable angina (a severe form in which chest pain occurs very frequently and 
with or without exertion); 
- if you have heart failure which has recently become worse; 
- if your heartbeat is exclusively imposed by your pacemaker; 
- if you suffer from severe liver problems; 
- if you are already taking medicines for the treatment of fungal infections (such as ketoconazole, 
itraconazole), macrolide antibiotics (such as josamycin, clarithromycin, telithromycin or 
erythromycin given orally), medicines to treat HIV infections (such as nelfinavir, ritonavir) or 
nefazodone (medicine to treat depression) or diltiazem, verapamil (used for high blood pressure or 
angina pectoris); 
- if you are a woman able to have children and not using reliable contraception; 
- if you are pregnant or trying to become pregnant; 
- if you are breast-feeding. </p>
<p>Warnings and precautions 
Talk to your doctor or pharmacist before taking Ivabradine Accord:</p>
<ul>
<li>if you suffer from heart rhythm disorders (such as irregular heartbeat, palpitation, increase in 
chest pain) or sustained atrial fibrillation (a type of irregular heartbeat), or an abnormality of 
electrocardiogram (ECG) called  long QT syndrome , </li>
<li>if you have symptoms such as tiredness, dizziness or shortness of breath (this could mean that 
your heart is slowing down too much), </li>
<li>if you suffer from symptoms of atrial fibrillation (pulse rate at rest unusually high (over 110 beats 
per minute) or irregular, without any apparent reason, making it difficult to measure), </li>
<li>if you have had a recent stroke (cerebral attack), </li>
<li>if you suffer from mild to moderate low blood pressure, </li>
<li>if you suffer from uncontrolled blood pressure, especially after a change in your antihypertensive 
treatment, </li>
<li>if you suffer from severe heart failure or heart failure with abnormality of ECG called  bundle 
branch block , </li>
<li>if you suffer from chronic eye retinal disease, </li>
<li>if you suffer from moderate liver problems, </li>
<li>if you suffer from severe renal problems. 
If any of the above applies to you, talk straight away to your doctor before or while taking Ivabradine 
Accord. </li>
</ul>
<p>Children and adolescents 
Do not give this medicine to children and adolescents younger than 18 years. Available data are 
insufficient in this age group. </p>
<p>Other medicines and Ivabradine Accord 
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other 
medicines. </p>
<p>Make sure to tell your doctor if you are taking any of the following medicines, as a dose adjustment of 
Ivabradine Accord or monitoring should be required:</p>
<ul>
<li>fluconazole (an antifungal medicine) </li>
<li>rifampicin (an antibiotic) </li>
<li>barbiturates (for difficult sleeping or epilepsy) </li>
<li>phenytoin (for epilepsy) </li>
<li>Hypericum perforatum or St John s Wort (herbal treatment for depression) </li>
<li>
<p>QT prolonging medicines to treat either heart rhythm disorders or other conditions:</p>
</li>
<li>
<p>quinidine, disopyramide, ibutilide, sotalol, amiodarone (to treat heart rhythm disorders) </p>
</li>
<li>bepridil (to treat angina pectoris) </li>
<li>certain types of medicines to treat anxiety, schizophrenia or other psychoses (such as pimozide, 
ziprasidone, sertindole) </li>
<li>anti-malarial medicines (such as mefloquine or halofantrine) </li>
<li>intravenous erythromycin (an antibiotic) </li>
<li>pentamidine (an antiparasitic medicine) </li>
<li>cisapride (against the gastro-oesophageal reflux) </li>
<li>some types of diuretics which may cause decrease in blood potassium level, such as furosemide, 
hydrochlorothiazide, indapamide (used to treat oedema, high blood pressure). </li>
</ul>
<p>Ivabradine Accord with food and drink<br />
Avoid grapefruit juice during treatment with Ivabradine Accord. </p>
<p>Pregnancy and breast-feeding 
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask 
your doctor or pharmacist for advice before taking this medicine. 
Do not take Ivabradine Accord if you are pregnant or are planning to have a baby (see  Do not take 
Ivabradine Accord ). 
If you are pregnant and have taken Ivabradine Accord, talk to your doctor. 
Do not take Ivabradine Accord if you are able to become pregnant unless you use reliable 
contraceptive measures (see  Do not take Ivabradine Accord ). 
Do not take Ivabradine Accord if you are breast-feeding (see  Do not take Ivabradine Accord ). Talk 
to your doctor if you are breast-feeding or intending to breast-feed as breast-feeding should be 
discontinued if you take Ivabradine Accord. </p>
<p>Driving and using machines 
Ivabradine Accord may cause temporary luminous visual phenomena (a temporary brightness in the 
field of vision, see  Possible side effects ). If this happens to you, be careful when driving or using 
machines at times when there could be sudden changes in light intensity, especially when driving at 
night. </p>
<p>Ivabradine Accord contains lactose 
If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor 
before taking this medicine. </p>         </div>"""   
                    
* section[=].section[+]
  * title =  "3. How to take ivabradine"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "3. How to take ivabradine"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor 
or pharmacist if you are not sure.<br />
Ivabradine Accord should be taken during meals. </p>
<p>Ivabradine Accord 5 mg tablet can be divided into equal doses. 
If you are being treated for stable angina pectoris 
The starting dose should not exceed one tablet of Ivabradine Accord 5 mg twice daily. If you still 
have angina symptoms and if you have tolerated the 5 mg twice daily dose well, the dose may be 
increased. </p>
<p>The maintenance dose should not exceed 7.5 mg twice daily. Your doctor will prescribe the right dose 
for you. The usual dose is one tablet in the morning and one tablet in the evening. In some cases (e.g. 
if you are aged 75 years or more), your doctor may prescribe half the dose i.e., one half 5 mg tablet of 
Ivabradine Accord 5 mg (corresponding to 2.5 mg ivabradine) in the morning and one half 5 mg tablet 
in the evening. </p>
<p>If you are being treated for chronic heart failure 
The usual recommended starting dose is one tablet of Ivabradine Accord 5 mg twice daily increasing 
if necessary to one tablet of Ivabradine Accord 7.5 mg twice daily. Your doctor will decide the right 
dose for you. The usual dose is one tablet in the morning and one tablet in the evening. In some cases 
(e.g. if you are aged 75 years or more), your doctor may prescribe half the dose i.e., one half 5 mg 
tablet of Ivabradine Accord 5 mg (corresponding to 2.5 mg ivabradine) in the morning and one half 
5 mg tablet in the evening. </p>
<p>If you take more Ivabradine Accord than you should 
A large dose of Ivabradine Accord could make you feel breathless or tired because your heart slows 
down too much. If this happens, contact your doctor immediately. </p>
<p>If you forget to take Ivabradine Accord 
If you forget to take a dose of Ivabradine Accord, take the next dose at the usual time. Do not take a 
double dose to make up for the forgotten dose. 
The calendar printed on the blister containing the tablets should help you remember when you last 
took a tablet of Ivabradine Accord. </p>
<p>If you stop taking Ivabradine Accord 
As the treatment for angina or chronic heart failure is usually life-long, you should discuss with your 
doctor before stopping this medicine. 
If you think that the effect of Ivabradine Accord is too strong or too weak, talk to your doctor or 
pharmacist. </p>
<p>If you have any further questions on the use of this medicine, ask your doctor or pharmacist. </p>         </div>"""         

        
* section[=].section[+]
  * title = "4. Possible side effects"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "4. Possible side effects"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Like all medicines, this medicine can cause side effects, although not everybody gets them. </p>
<p>The most common adverse reactions with this medicine are dose dependent and related to its mode of 
action: </p>
<p>Very common (may affect more than 1 in 10 people) 
Luminous visual phenomena (brief moments of increased brightness, most often caused by sudden 
changes in light intensity). They can also be described as a halo, coloured flashes, image 
decomposition or multiple images. They generally occur within the first two months of treatment after 
which they may occur repeatedly and resolve during or after treatment </p>
<p>Common (may affect up to 1 in 10 people) 
Modification in the heart functioning (the symptoms are a slowing down of the heart rate). They 
particularly occur within the first 2 to 3 months of treatment initiation. </p>
<p>Other side effects </p>
<p>Common (may affect up to 1 in 10 people) 
Irregular rapid contraction of the heart (Atrial fibrillation), abnormal perception of heartbeat 
(Bradycardia, Ventricular extrasystoles, AV 1st degree block (ECG prolonged PQ interval)), 
uncontrolled blood pressure, headache, dizziness and blurred vision (cloudy vision). </p>
<p>Uncommon (may affect up to 1 in 100 people) 
Palpitations and cardiac extra beats, feeling sick (nausea), constipation, diarrhoea, abdominal pain, 
spinning sensation (vertigo), difficulty breathing (dyspnoea), muscle spasms, high blood levels of uric 
acid, an excess of eosinophils (a type of white blood cell) and elevated creatinine in blood (a 
breakdown product of muscle), skin rash, angioedema (such as swollen face, tongue or throat, 
difficulty in breathing or swallowing), low blood pressure, fainting, feeling of tiredness, feeling of 
weakness, abnormal ECG heart tracing, double vision, impaired vision. </p>
<p>Rare (may affect up to 1 in 1,000 people) 
Urticaria, itching, skin reddening, feeling unwell. </p>
<p>Very rare (may affect up to 1 in 10,000 people) 
Irregular heart beats (AV 2nd degree block, AV 3rd degree block, Sick sinus syndrome). </p>
<p>Reporting of side effects 
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects 
not listed in this leaflet. You can also report side effects directly via the national reporting system 
listed in Appendix V. By reporting side effects you can help provide more information on the safety 
of this medicine. </p>         </div>"""      
        
* section[=].section[+]
  * title = "5. How to store ivabradine"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "5. How to store ivabradine"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Keep this medicine out of the sight and reach of children. </p>
<p>Do not use this medicine after the expiry date which is stated on the carton and blister after EXP. The 
expiry date refers to the last day of that month. </p>
<p>This medicine does not require any special storage conditions. </p>
<p>Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to 
throw away medicines you no longer use. These measures will help protect the environment. </p>         </div>"""      
        
        
* section[=].section[+]
  * title = "6. Contents of the pack and other information"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "6. Contents of the pack and other information"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>What Ivabradine Accord contains 
- The active substance is ivabradine (as hydrochloride). </p>
<p>Ivabradine Accord 5 mg film-coated tablets:  </p>
<p>Each film-coated tablet contains 5 mg ivabradine (as hydrochloride). </p>
<p>Ivabradine Accord 7.5 mg film-coated tablets::<br />
Each film-coated tablet contains 7.5 mg ivabradine (as hydrochloride). </p>
<p>The other ingredients are: 
 tablet core: lactose anhydrous (see section 2), magnesium stearate (E470b), pregelatinised starch 
(maize), colloidal hydrated silica (E551),<br />
film coating: polyvinyl alcohol (E1203), titanium dioxide (E171), macrogol (4000), talc (E553b), 
yellow iron oxide (E172), red iron oxide (E172). </p>
<p>What Ivabradine Accord looks like and contents of the pack 
Ivabradine Accord 5 mg film-coated tablets are salmon-coloured, oblong shaped ,film-coated tablets 
scored on both sides, debossed with  FK  on one side and  2  on other side. 
Ivabradine Accord 7.5 mg film-coated tablets are salmon-coloured, triangular shaped, film-coated 
tablets debossed with  FK  on one side and  1 on other side. </p>
<p>The tablets are available in Aluminium/Aluminium perforated unit dose blister in pack-sizes of 14x1, 
28x1, 56x1, 84x1, 98x1, 100x1 or 112x1 tablets. 
Not all pack sizes may be marketed. 
Marketing Authorisation Holder and Manufacturer </p>
<p>Marketing Authorisation Holder: 
Accord Healthcare S.L.U. 
World Trade Center, Moll de Barcelona, s/n, 
Edifici Est 6  planta, 
08039 Barcelona, 
Spain </p>
<p>Manufacturer: </p>
<p>Laboratori Fundacio Dau 
C/ C, 12-14 Pol. Ind. Zona Franca 
08040 Barcelona 
Spain </p>
<p>or </p>
<p>WESSLING Hungary Kft., 
Anonymus u. 6., Budapest, 1045, 
Hungary </p>
<p>or </p>
<p>Accord Healthcare Polska Sp.z o.o., 
ul. Lutomierska 50,95-200 Pabianice, Poland </p>
<p>This leaflet was last revised in. </p>
<p>Other sources of information </p>
<p>Detailed information on this medicine is available on the European Medicines Agency web site: </p>         </div>"""      

